|
Status |
Public on Nov 24, 2021 |
Title |
Group-2 Innate Lymphoid Cells Promote Hepatocellular Carcinoma Progression via CXCL2-Neutrophil Induced Immunosuppression |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
We report a tissue-derived KLRG1-ILC2s highly expressing CD69 in HCC, which are distinguished from circulating ones from portal vein and peripheral blood. Relief of KLRG1 inhibitory signaling, the HCC-induced ILC2s tend to shape an immunosuppressive tumor microenvironment through CXCL2/neutrophil axis. Furthermore, the abundance of ILC2s in HCC correlated with the recurrence and progression free survival (PFS) of HCC patients indicated ILC2s being an emerging target for HCC immunotherapy.
|
|
|
Overall design |
mRNA profiles of ILC2s from HCC and non-tumoral tissues as well as naïve T cells from circulation
|
|
|
Contributor(s) |
Xu X, Ye L, Liang T |
Citation(s) |
33829508 |
|
Submission date |
Jun 05, 2020 |
Last update date |
Nov 24, 2021 |
Contact name |
Xingyuan Xu |
E-mail(s) |
21418081@zju.edu.cn
|
Organization name |
the First Affiliated Hospital, Zhejiang University school of medicine
|
Street address |
No.79 qingchun road
|
City |
Hangzhou |
ZIP/Postal code |
310003 |
Country |
China |
|
|
Platforms (1) |
|
Samples (8)
|
|
Relations |
BioProject |
PRJNA637600 |
SRA |
SRP266142 |